| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/28/2013 | CN102093320B Soluble epoxide hydrolase inhibitor |
| 08/28/2013 | CN102089006B Compositions and methods for producing vascular occlusion using solid-phase platelet binding agent |
| 08/28/2013 | CN102083424B Methods and use of inducing apoptosis in cancer cells |
| 08/28/2013 | CN102078385B External fig ointment |
| 08/28/2013 | CN102065696B Versatile disinfectant |
| 08/28/2013 | CN102026974B Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 08/28/2013 | CN102015681B Crystal form of phenylamino pyrimidine derivatives |
| 08/28/2013 | CN101986781B Crystalline I-(3-fluorophenyl)-5-methyl-2-(1H)pyridone, the preparation methods, compositions and applications thereof |
| 08/28/2013 | CN101982464B Annonaceous acetogenin compound and synthesis method and application thereof |
| 08/28/2013 | CN101981035B Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments |
| 08/28/2013 | CN101981006B Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/28/2013 | CN101914031B Pregabalin derivative and application thereof |
| 08/28/2013 | CN101910177B Macrocyclic indoles as hepatitis C virus inhibitors |
| 08/28/2013 | CN101904946B Full-effect tea-lavender fat-suppression formulation with natural activity |
| 08/28/2013 | CN101870689B 3-(1-halogenated methylene) sulphur chromane-4-ketone compound as well as preparation method and application thereof |
| 08/28/2013 | CN101856429B Medicine compound with visual fatigue relieving function and preparation method thereof |
| 08/28/2013 | CN101849998B Plaster for treating hepatitis B and using method thereof |
| 08/28/2013 | CN101830819B Phenylbutyryl curcumin derivate and application thereof in anti-tumor drug preparation |
| 08/28/2013 | CN101827599B Process for synthesizing phosphonic and phosphinic acid compounds |
| 08/28/2013 | CN101820884B Phenothiazine compounds for treating mild cognitive impairment |
| 08/28/2013 | CN101808516B Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of MEK as well as compositions, methods of use and methods for preparing the same |
| 08/28/2013 | CN101801520B Process for producing fine particles and the fine particles |
| 08/28/2013 | CN101787016B Pyridine carboxamides as 11-beta-hsd1 inhibitors |
| 08/28/2013 | CN101772308B Use of probiotics and fibers for diarrhoea |
| 08/28/2013 | CN101744805B Use of amentoflavone biflavone as only active component in curing viral diseases |
| 08/28/2013 | CN101732290B Stable solid formulation of egualen sodium |
| 08/28/2013 | CN101679325B Modulators of pharmacokinetic properties of therapeutics |
| 08/28/2013 | CN101553456B Crystalline potassium salt of lipoxin A4 analogs |
| 08/28/2013 | CN101535276B Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors |
| 08/28/2013 | CN101516359B Medicament for LCT poisoning |
| 08/28/2013 | CN101489575B FKBP-L and uses thereof |
| 08/28/2013 | CN101478973B Novel silicone film former for delivery of actives |
| 08/28/2013 | CN101475619B Preparation and use of Linaria vulgaris flavone and total flavone thereof |
| 08/28/2013 | CN101474299B Pharmaceutical composition for reducing blood sugar, blood fat and treating diabetes |
| 08/28/2013 | CN101432281B 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling |
| 08/28/2013 | CN101423492B Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same |
| 08/28/2013 | CN101410371B Process for production of carotenoid |
| 08/28/2013 | CN101361718B Stable preparation method of decitabine freeze-dry preparation |
| 08/28/2013 | CN101300259B Tricyclic spiro derivatives as CRTH2 modulators |
| 08/28/2013 | CN101273977B Preparation technique of tryptanthrin preparations and uses thereof |
| 08/28/2013 | CN101248049B 咪唑类lxr调节剂 Imidazole lxr modifier |
| 08/28/2013 | CN101248048B Imidazole based LXR modulators |
| 08/28/2013 | CN101194017B Conjugate comprising P21 protein for the treatment of cancer |
| 08/27/2013 | US8519189 Polymers for reversing heparin-based anticoagulation |
| 08/27/2013 | US8519188 Compounds which can be used for the treatment of cancers |
| 08/27/2013 | US8519183 Uses for amino acid anticonvulsants |
| 08/27/2013 | US8519169 Crystallization a 1alpha-hydroxy-20-methyl-2-methylene-19,24,25,26,27-pentanorvitamin D3 |
| 08/27/2013 | US8519159 Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-OL and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-OL analogues, and novel 3,6-disubstituted pyran derivatives |
| 08/27/2013 | US8519155 Choline and tromethamine salt of licofelone |
| 08/27/2013 | US8519154 Method for treatment of bronchial asthma |
| 08/27/2013 | US8519149 Tricyclic compounds as mPGES-1 inhibitors |
| 08/27/2013 | US8519145 Aryl compounds as PPAR ligands and their use |
| 08/27/2013 | US8519142 Aryl pyridine as aldosterone synthase inhibitors |
| 08/27/2013 | US8519140 Method for synthesizing pirfenidone |
| 08/27/2013 | US8519137 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 08/27/2013 | US8519136 Aminopyridine derivatives having aurora a selective inhibitory action |
| 08/27/2013 | US8519135 Heteroaryl sulfonamides and CCR2/CCR9 |
| 08/27/2013 | US8519134 Aryl-pyridine derivatives as aldosterone synthase inhibitors |
| 08/27/2013 | US8519129 Pyrimidine derivatives as kinase inhibitors |
| 08/27/2013 | US8519109 Tumour rejection antigens |
| 08/27/2013 | US8519058 Crosslinked polymers containing biomass derived materials |
| 08/27/2013 | US8519010 Antimicrobial compositions |
| 08/27/2013 | US8519008 ration including sugar alcohol to be fed to lactating swine to increase weight gain and backfat thickness of nursing piglets |
| 08/27/2013 | US8519007 Use certain diterpene compounds in the treatment of androgen receptor-associated diseases |
| 08/27/2013 | US8519006 Use of sphingosine-1 phosphate (S1P) receptor agonists for the treatment of brain degenerative diseases |
| 08/27/2013 | US8519005 prevent, reduce, and/or reverse toxicities such as gastrointestinal toxicity, renal damage, mucosal damage, endothelial dysfunction, ischemia, and platelet dysfunction produced by antinflammatory drugs; concurrent administration of MAO inhibitor |
| 08/27/2013 | US8519004 Dosing regimes for trans-clomiphene |
| 08/27/2013 | US8519001 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
| 08/27/2013 | US8519000 Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators |
| 08/27/2013 | US8518999 Modulators of TNF-αsignaling |
| 08/27/2013 | US8518998 Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid N-phenylamides in the treatment of pain |
| 08/27/2013 | US8518997 4-(phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 08/27/2013 | US8518996 Aqueous intraocular penetration-promoting eye drop |
| 08/27/2013 | US8518995 Methods and compositions for the treatment of irritable bowel syndrome |
| 08/27/2013 | US8518993 Combination of bioavailable methionine with at least one essential oil |
| 08/27/2013 | US8518992 Method of synthesis and purification of N-6-trimethyl-L-lysine and derivative compounds |
| 08/27/2013 | US8518990 Cancer treatment |
| 08/27/2013 | US8518989 Prodrugs of short-chain fatty acids and treatment methods |
| 08/27/2013 | US8518988 Polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphthalenyl) ester |
| 08/27/2013 | US8518987 Pseudopolymorphic forms of a HIV protease inhibitor |
| 08/27/2013 | US8518986 Compositions containing retinoid and chromenone derivatives |
| 08/27/2013 | US8518985 Haloalkylmethyleneoxyphenyl-substituted ketoenols |
| 08/27/2013 | US8518984 Spiro-oxindole MDM2 antagonists |
| 08/27/2013 | US8518983 P38 inhibitors and methods of use thereof |
| 08/27/2013 | US8518981 Liquid pharmaceutical formulations of palonosetron |
| 08/27/2013 | US8518980 Treatment of Duchenne muscular dystrophy |
| 08/27/2013 | US8518979 Alpha-halo- and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof |
| 08/27/2013 | US8518978 Pharmaceutical composition for prevention and treatment of restenosis comprising isoxazole derivatives |
| 08/27/2013 | US8518977 Benzamides and related inhibitors of factor XA |
| 08/27/2013 | US8518975 Gamma secretase modulators |
| 08/27/2013 | US8518974 Isoxazolo-pyridine derivatives |
| 08/27/2013 | US8518973 Compounds having 4-pyridylalkylthio group as a substituent |
| 08/27/2013 | US8518972 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same |
| 08/27/2013 | US8518970 Compounds and methods of use |
| 08/27/2013 | US8518969 Cyclohexyl-azetidinyl antagonists of CCR2 |
| 08/27/2013 | US8518968 Hydrazone and diacyl hydrazine compounds and methods of use |
| 08/27/2013 | US8518967 Amides of acetic and propionic acids |
| 08/27/2013 | US8518966 Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 08/27/2013 | US8518965 Compositions and methods for treating cancer |
| 08/27/2013 | US8518964 Tricyclic compounds useful as inhibitors of kinases |